Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 10/2006

01-10-2006 | Review

Type 2 diabetes and cardiovascular risk in the UK south Asian community

Authors: A. H. Barnett, A. N. Dixon, S. Bellary, M. W. Hanif, J. P. O’Hare, N. T. Raymond, S. Kumar

Published in: Diabetologia | Issue 10/2006

Login to get access

Abstract

A popular hypothesis for the greater prevalence of type 2 diabetes and cardiovascular disease in UK south Asians is that they have an increased susceptibility of developing insulin resistance in response to certain environmental factors, including obesity and adoption of a sedentary lifestyle. Insulin resistance is postulated as a central feature of the metabolic syndrome, culminating in type 2 diabetes, atherosclerotic vascular disease and CHD; a pathway potentially accelerated by migration/urbanisation. We describe and compare the prevalence of type 2 diabetes, cardiovascular disease and their associated risk factors in UK south Asian and white Caucasian populations to determine possible reasons for the increased preponderance of these diseases in south Asians, and highlight key evidence for optimal risk factor management. Finally, we describe a UK community-based programme that attempts to reduce the morbidity and mortality from type 2 diabetes and cardiovascular disease in south Asians through a new approach to management.
Literature
1.
2.
Cappuccio FP, Cook DG, Atkinson RW, Wicks PD (1998) The Wandsworth heart and stroke study. A population-based survey of cardiovascular risk factors in different ethnic groups. Methods and baseline findings. Nutr Metab Cardiovasc Dis 8:371–385
3.
Jenum AK, Holme I, Graff-Iversen S, Birkeland KI (2005) Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention. Diabetologia 48:435–439PubMedCrossRef
4.
McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386PubMedCrossRef
5.
McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG (1993) Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinaemia. Circulation 87:152–161PubMed
6.
Mohanty SA, Woolhandler S, Himmelstein DU, Bor DH (2005) Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med 20:474–488PubMedCrossRef
7.
Anand SS, Yusuf S, Vuksan V et al (2000) Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356:279–284PubMedCrossRef
8.
Balarajan R (1991) Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 302:560–564PubMed
9.
McKeigue PM, Marmot MG (1988) Mortality from coronary heart disease in Asian communities in London. BMJ 297:903PubMed
10.
Wild S, McKeigue P (1997) Cross sectional analysis of mortality by country of birth in England and Wales, 1970–92. BMJ 314:705PubMed
11.
UK Prospective Diabetes Study Group (1998) Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (UK Prospective Diabetes Study 32). Diabetes Care 21:1271–1277CrossRef
12.
Woodward M, Zhang X, Barzi F et al (2003) The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 26:360–366PubMedCrossRef
13.
Fischbacher CM, Bhopal R, Rutter MK et al (2003) Microalbuminuria is more frequent in South Asian than in European origin populations: a comparative study in Newcastle, UK. Diabet Med 20:31–36PubMedCrossRef
14.
Mather HM, Keen H (1985) The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 291:1081–1084
15.
Simmons D, Williams DR, Powell MJ (1989) Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry Diabetes Study. BMJ 298:18–21PubMed
16.
Health Survey for England (2001) The health of minority ethnic groups ’99. The Stationery Office, London
17.
UK Prospective Diabetes Study Group (1994) UK Prospective Diabetes Study XII: differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med 11:670–677CrossRef
18.
Bodansky HJ, Staines A, Stephenson C et al (1992) Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ 304:1020–1022PubMedCrossRef
19.
Staines A, Hanif S, Ahmed S et al (1997) The incidence of insulin dependent diabetes mellitus in Karachi, Pakistan. Arch Dis Child 76:121–123PubMed
20.
Feltbower RG, Bodansky HJ, McKinney PA et al (2002) Trends in the incidence of type 1 diabetes in south Asians and other children in Bradford, UK. Diabet Med 19:162–166PubMedCrossRef
21.
Chaturvedi N, Fuller JH (1996) Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes? J Epidemiol Community Health 50:137–139PubMed
22.
Wilkinson P, Sayer J, Laji K et al (1996) Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ 312:1330–1333PubMed
23.
McKeigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South Asians overseas—review. J Clin Epidemiol 422:597–609CrossRef
24.
Shaukat N, DeBono DP, Jones DR (1994) A comparison of risk factors in south Asian and north European coronary artery patients with their young male offspring. Br Heart J 71:27
25.
Hughes LO, Raval U, Raftery EB (1989) First myocardial infarctions in Asian and white men. BMJ 298:1345–1350PubMed
26.
Lowry PJ, Glover DR, Mace PJ, Littler WA (1984) Coronary artery disease in Asians in Birmingham. Br Heart J 52:610–613PubMed
27.
Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N (1990) Epidemiological study of coronary heart disease in urban population of Delhi. Indian J Med Res 92:424–430PubMed
28.
Gupta R, Gupta VP, Ahluwalia NS (1994) Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India. BMJ 309:1332–1336PubMed
29.
Verma NP, Mehta SP, Madhu S, Mather HM, Keen H (1986) Prevalence of known diabetes in an urban Indian environment: the Darya Ganj Diabetes Survey. Br Med J (Clin Res Ed) 293:423–424CrossRef
30.
Ramachandran A, Snehalatha C, Baskar AD et al (2004) Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia 47:860–865PubMedCrossRef
31.
Ramachandran A, Snehalatha C, Kapur A et al (2001) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094–1101PubMedCrossRef
32.
Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G (2005) Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf) 27:93–100CrossRef
33.
Chambers JC, Wrigley J, Kooner JS (2000) Evaluation of the Joint British Societies coronary heart disease risk calculator in UK South Asians. Heart 83(Suppl):43A
34.
Aarabi M, Jackson PR (2005) Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools. Eur J Cardiovasc Prev Rehabil 12:46–51PubMedCrossRef
35.
Ehtisham S, Crabtree N, Clark P, Shaw N, Barrett T (2005) Ethnic differences in insulin resistance and body composition in UK adolescents. J Clin Endocrinol Metab 90:3963–3969PubMedCrossRef
36.
Whincup PH, Gilg JA, Papacosta O et al (2002) Early evidence of ethnic differences in cardiovascular disease risk: cross sectional comparison of British South Asian and white children. BMJ 324:635PubMedCrossRef
37.
McTernan P, Kumar S (2004) Pathogenesis of obesity-related type 2 diabetes. In: Barnett AH, Kumar S (eds) Obesity and diabetes. Wiley, Chichester, pp 49–78CrossRef
38.
Ramachandran A, Snehalatha C, Dharmaraj D, Viswanathan M (1992) Prevalence of glucose intolerance in Asian Indians. Urban–rural difference and significance of upper body adiposity. Diabetes Care 15:1348–1355PubMedCrossRef
39.
40.
Working Party of the Royal College of Physicians (2004) Storing up problems: the medical cure for a slimmer nation. Royal College of Physicians, London, p 3
41.
Valsamakis G, Chetty R, Anwar A, Banerjee AK, Barnett A, Kumar S (2004) Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med 21:1339–1345PubMedCrossRef
42.
Krishnaveni GV, Hill JC, Veena SR et al (2005) Truncal adiposity is present at birth and in early childhood in south Indian children. Indian Pediatr 42:527–538PubMed
43.
Godfrey KM, Barker DJP (2000) Fetal nutrition and adult disease. Am J Clin Nutrition 71:1344S–1352S
44.
Dhawan J, Bray CL (1997) Asian Indians, coronary artery disease, and physical exercise. Heart 78:550–554PubMed
45.
Fischbacher CM, Hunt S, Alexander L (2004) How physically active are South Asians in the United Kingdom? A literature review. J Public Health (Oxf) 26:250–258CrossRef
46.
Cruickshank JK, Jackson SH, Bannan LT, Beevers DG, Beevers M, Osbourne VL (1983) Blood pressure in black, white and Asian factory workers in Birmingham. Postgrad Med J 59:622–626PubMedCrossRef
47.
Mather HM, Chaturvedi N, Fuller JH (1998) Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med 15:53–59PubMedCrossRef
48.
Davis TM, Cull CA, Holman RR; UK Prospective Diabetes Study (UKPDS) Group (2001) Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: UK Prospective Diabetes Study (UKPDS 55). Diabetes Care 24:1167–1174PubMedCrossRef
49.
Hughes LO, Woiciechowski AP, Raftery EB (1990) Relationship between plasma cholesterol and coronary artery disease in Asians. Atherosclerosis 83:5–20CrossRef
50.
Bhatnager D, Anand IS, Durrington PN et al (1995) Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 345:405–409CrossRef
51.
Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP (1999) Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol 19:2749–2755PubMed
52.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421
53.
Misra A, Vikram NK, Arya S et al (1998) Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 21:1819–1823CrossRef
54.
Shaukat N, de Bono DP, Jones DR (1995) Like father like son? Sons of patients of European or Indian origin with coronary artery disease reflect their parents’ risk factor patterns. Br Heart J 74:318–323PubMed
55.
56.
Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818PubMed
57.
Chambers JC, Eda S, Bassett P et al (2001) C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104:145–150PubMed
58.
Forouhi NG, Sattar N, McKeigue PM (2001) Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 25:1327–1331PubMedCrossRef
59.
Cook DG, Mendall MA, Whincup PH et al (2000) C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149:139–150PubMedCrossRef
60.
Mohan V, Deepa R, Pradeepa R et al (2005) Association of low adiponectin levels with the metabolic syndrome—the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 54:476–481PubMedCrossRef
61.
Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A (2003) Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26:3226–3229PubMedCrossRef
62.
Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S (2003) Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 5:131–135PubMedCrossRef
63.
Chambers JC, McGregor A, Jean-Marie J, Kooner JS (1999) Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians. Heart 81:501–504PubMed
64.
Kain K, Catto AJ, Grant PJ (2001) Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects. Atherosclerosis 156:457–461PubMedCrossRef
65.
Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS (1996) Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Diabet Med 13:59–64PubMedCrossRef
66.
Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V (2001) Absence of association between serum homocysteine levels and coronary artery disease in south Indian males. Indian Heart J 53:44–47PubMed
67.
Chambers JC, Obeid OA, Refsum H et al (2000) Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 355:523–527PubMedCrossRef
68.
Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38:1239–1245PubMedCrossRef
69.
Pittas AG, Li T, Willett WC, Manson JE, Dawson-Hughes B, Hu FB (2005) A prospective study of vitamin D intake and risk of type 2 diabetes in women. Presented at: American Diabetes Association 65th Scientific Session; June 10–14, San Diego, CA: 1772P (Abstract)
70.
Ramachandran A, Snehalatha C, Latha E, Satyavani K, Vijay V (1998) Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care 21:967–971PubMedCrossRef
71.
Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF (2005) Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 48:649–656PubMedCrossRef
72.
International Diabetes Federation (2005) The IDF consensus worldwide definition of the metabolic syndrome. Available from http://​www.​idf.​org, last accessed May 2006
73.
Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304PubMedCrossRef
74.
75.
Abate N, Carulli L, Cabo-Chan A, Chandalia M, Snell PG, Grundy SM (2003) Genetic polymorphism PC-1 K121Q and the ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab 88:5927–5934PubMedCrossRef
76.
Yusuf S, Hawken S, Ounpuu S (2004) Effects of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364:937–952PubMedCrossRef
77.
Gupta R, Singhal S (1997) Coronary heart disease in India. Circulation 96:3785PubMed
78.
Patel JV, Vyas A, Cruickshank JK et al (2006) Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis 185:297–306PubMedCrossRef
79.
80.
Jacobson MS (1987) Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet 2:656–658PubMedCrossRef
81.
Singh RB, Mori H, Chen J et al (1996) Recommendations for the prevention of coronary artery disease in Asians: a scientific statement of the International College of Nutrition. J Cardiovasc Risk 3:489–494PubMedCrossRef
82.
Bhalodkar NC, Blum S, Rana T, Bhalodkar A, Kitchappa R, Enas EA (2005) Effect of leisure time exercise on high-density lipoprotein cholesterol, its subclasses, and size in Asian Indians. Am J Cardiol 96:98–100PubMedCrossRef
83.
McKeigue P (2000) Development of interventions to reduce the risk of CHD in South Asians (WE1). The Research Findings Register. Summary number 116. Available from http://​www.​ReFeR.​nhs.​uk, last accessed May 2006
84.
Heart Protection Study Collaborative Group (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016CrossRef
85.
Colhoun HM, Betteridge DJ, Durrington PN et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696PubMedCrossRef
86.
Lawrence IG, McNally PG (2001) Heart disease in Asian people with diabetes. Practical Diabetes Int 18:192–196CrossRef
87.
Rubins HB, Robins SJ, Collins D et al (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 341:410–418PubMedCrossRef
88.
FIELD Study Investigators (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD Study): randomised controlled trial. Lancet 366:1849–1861CrossRef
89.
Kashyap ML, McGovern ME, Berra K et al (2002) Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. Am J Cardiol 89:672–678PubMedCrossRef
90.
Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583–1592PubMedCrossRef
91.
Hansson L, Zanchetti A, Carruthers SG et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351:1755–1762PubMedCrossRef
92.
93.
Ford S, Mai F, Manson A, Rukin N, Dunne F (2000) Diabetes knowledge—are patients getting the message? Int J Clin Pract 54:535–536PubMed
94.
Hawthorne K (2001) Effect of culturally appropriate health education on glycaemic control and knowledge of diabetes in British Pakistani women with type 2 diabetes mellitus. Health Educ Res 16:373–381PubMedCrossRef
95.
Rankin J, Bhopal R (2001) Understanding of heart disease and diabetes in a South Asian community: cross-sectional study testing the ‘snowball’ sample method. Public Health 115:253–260PubMed
96.
Vyas A, Haidery AZ, Wiles PG, Gill S, Roberts C, Cruickshank JK (2003) A pilot randomized trial in primary care to investigate and improve knowledge, awareness and self-management among South Asians with diabetes in Manchester. Diabet Med 20:1022–1026PubMedCrossRef
97.
Patel MG, Wright DJ, Gill PS, Jerwood D, Silcok J, Chrystyn H (2002) Prescribing of lipid lowering drugs so South Asian patients: ecological study. BMJ 325:25–26PubMedCrossRef
98.
O’Hare JP, Raymond NT, Mughal S et al (2004) Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS). Diabetic Med 21:1357–1365PubMedCrossRef
99.
Ward PR, Noyce PR, St Leger AS (2005) Multivariate regression analysis of associations between general practitioner prescribing rates for coronary heart disease drugs and healthcare needs indicators. J Epidemiol Community Health 59:86PubMed
100.
Cruikshank K, Pickup J, Williams G, (eds) (1997) Textbook of diabetes, vol 1, 2nd edn. Blackwell Science, Oxford, p 3.21
Metadata
Title
Type 2 diabetes and cardiovascular risk in the UK south Asian community
Authors
A. H. Barnett
A. N. Dixon
S. Bellary
M. W. Hanif
J. P. O’Hare
N. T. Raymond
S. Kumar
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0325-1

Other articles of this Issue 10/2006

Diabetologia 10/2006 Go to the issue

Article

Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing

Article

The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy

Article

Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice

Article

Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone

Article

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes

Article

Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits